(Q44188484)
Statements
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia (English)
K A Becker
21 February 2013
scientific article published on 21 February 2013